Detalhe da pesquisa
1.
Mast Cells Regulate Ductular Reaction and Intestinal Inflammation in Cholestasis Through Farnesoid X Receptor Signaling.
Hepatology
; 74(5): 2684-2698, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34164827
2.
Mast Cells Induce Ductular Reaction Mimicking Liver Injury in Mice Through Mast Cell-Derived Transforming Growth Factor Beta 1 Signaling.
Hepatology
; 73(6): 2397-2410, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32761972
3.
Mast Cells Promote Nonalcoholic Fatty Liver Disease Phenotypes and Microvesicular Steatosis in Mice Fed a Western Diet.
Hepatology
; 74(1): 164-182, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33434322
4.
Amelioration of Large Bile Duct Damage by Histamine-2 Receptor Vivo-Morpholino Treatment.
Am J Pathol
; 190(5): 1018-1029, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32142732
5.
Biliary damage and liver fibrosis are ameliorated in a novel mouse model lacking l-histidine decarboxylase/histamine signaling.
Lab Invest
; 100(6): 837-848, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32054995
6.
Prolonged intake of desloratadine: mesenteric lymphatic vessel dysfunction and development of obesity/metabolic syndrome.
Am J Physiol Gastrointest Liver Physiol
; 316(1): G217-G227, 2019 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30475062
7.
Knockout of l-Histidine Decarboxylase Prevents Cholangiocyte Damage and Hepatic Fibrosis in Mice Subjected to High-Fat Diet Feeding via Disrupted Histamine/Leptin Signaling.
Am J Pathol
; 188(3): 600-615, 2018 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-29248461
8.
Blocking H1/H2 histamine receptors inhibits damage/fibrosis in Mdr2-/- mice and human cholangiocarcinoma tumorigenesis.
Hepatology
; 68(3): 1042-1056, 2018 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-29601088
9.
Ursodeoxycholate inhibits mast cell activation and reverses biliary injury and fibrosis in Mdr2-/- mice and human primary sclerosing cholangitis.
Lab Invest
; 98(11): 1465-1477, 2018 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30143751
10.
Bile duct ligation-induced biliary hyperplasia, hepatic injury, and fibrosis are reduced in mast cell-deficient KitW-sh mice.
Hepatology
; 65(6): 1991-2004, 2017 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-28120369
11.
Updates on Dietary Models of Nonalcoholic Fatty Liver Disease: Current Studies and Insights.
Gene Expr
; 18(1): 5-17, 2018 03 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-29096730
12.
The emerging role of mast cells in liver disease.
Am J Physiol Gastrointest Liver Physiol
; 313(2): G89-G101, 2017 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28473331
13.
Inhibition of Mast Cell-Derived Histamine Decreases Human Cholangiocarcinoma Growth and Differentiation via c-Kit/Stem Cell Factor-Dependent Signaling.
Am J Pathol
; 186(1): 123-33, 2016 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-26597881
14.
Inhibition of mast cell-secreted histamine decreases biliary proliferation and fibrosis in primary sclerosing cholangitis Mdr2(-/-) mice.
Hepatology
; 64(4): 1202-1216, 2016 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-27351144
15.
Isolation and characterization of hepatic mast cells from cholestatic rats.
Lab Invest
; 96(11): 1198-1210, 2016 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-27548803
16.
Knockout of microRNA-21 reduces biliary hyperplasia and liver fibrosis in cholestatic bile duct ligated mice.
Lab Invest
; 96(12): 1256-1267, 2016 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-27775690
17.
Regulation of the histamine/VEGF axis by miR-125b during cholestatic liver injury in mice.
Am J Pathol
; 184(3): 662-73, 2014 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-24384130
18.
Inhibition of mast cell-derived histamine secretion by cromolyn sodium treatment decreases biliary hyperplasia in cholestatic rodents.
Lab Invest
; 94(12): 1406-18, 2014 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-25365204
19.
Knockout of histidine decarboxylase decreases bile duct ligation-induced biliary hyperplasia via downregulation of the histidine decarboxylase/VEGF axis through PKA-ERK1/2 signaling.
Am J Physiol Gastrointest Liver Physiol
; 307(8): G813-23, 2014 Oct 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-25169977
20.
Overexpression of membrane metalloendopeptidase inhibits substance P stimulation of cholangiocarcinoma growth.
Am J Physiol Gastrointest Liver Physiol
; 306(9): G759-68, 2014 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-24603459